Neurodegenerative Disorder-Targeting Compound 1
Names
[ CAS No. ]:
1254699-12-1
[ Name ]:
Neurodegenerative Disorder-Targeting Compound 1
Biological Activity
[Description]:
Neurodegenerative Disorder-Targeting Compound 1 is a carboxamide compound, used in the research of neurodegenerative disorders.
[Related Catalog]:
[In Vitro]
Neurodegenerative Disorder-Targeting Compound 1 can be used in the research of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease[1].
[References]
[1]. MACK, Helmut., et al. CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS. WO 2010128102 A1.
[Related Small Molecules]
Captisol
|
Cyclosporin A
|
H2DCFDA
|
0MPTP hydrochloride
|
GW4869
|
Etomoxir
|
TD139
|
Mitoquinone mesylate
|
GSK2795039
|
JC-1
|
BAPTA-AM
|
AP 20187
|
Setanaxib (GKT137831)
|
D-Luciferin
|
Crotaline
Chemical & Physical Properties
[ Molecular Formula ]:
C28H28N4O4
[ Molecular Weight ]:
484.55
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.